Skip Nav Destination
Article navigation
December 1987
Conference Abstract|
December 01 1987
Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine
S.H. Morgan;
S.H. Morgan
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
P. Purkiss;
P. Purkiss
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
E.R. Maher;
E.R. Maher
∗Dept. Medicine, Charing Cross Hospital, London, UK
Search for other works by this author on:
R.W.E. Watts;
R.W.E. Watts
1Clinical Research Centre, Harrow HA1 3UJ, UK
Search for other works by this author on:
J.R. Curtis
J.R. Curtis
∗Dept. Medicine, Charing Cross Hospital, London, UK
Search for other works by this author on:
Clin Sci (Lond) (1987) 73 (s17): 41P.
Citation
S.H. Morgan, P. Purkiss, E.R. Maher, R.W.E. Watts, J.R. Curtis; Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine. Clin Sci (Lond) 1 December 1987; 73 (s17): 41P. doi: https://doi.org/10.1042/cs073041Pc
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.